Sort By:
TruScreen Appoints Dexter Cheung as Chair of Technology Committee
Results of Annual General Meeting
Annual Shareholders Meeting Presentation
TruScreen outperforms Pap Smear in Saudi Arabia Study
TruScreen Pty Ltd – Change of Operations Address
TruScreen has moved into a new office in Lane Cove West
TruScreen Commences Major Commercial Rollout in Vietnam
Commercial activities ramp up in Vietnam after the MOH listing of TruScreen 065c789v948zsw (1)
TruScreen Annual Report FY2024
TruScreen Annual Report and Finacial Statement for Finacial Year 2024 TRU Annual Report - FY2024
TruScreen Wins Top Prize in Poland’s Institute for Mother and Child Startup Challange
TruScreen included on the Vietnamese Ministry of Health Approved Technology List
TruScreen Awarded Zimbabwe Tender
TruScreen Half Year Results
NZX | ASX - HALFYR | Half Yearly Report, Half Year Accounts
TruScreen Half Year Results Template
NZX | ASX - HALFYR | Half Yearly Report, Half Year Accounts
Director and Officer Disclosure Notice
Strong Sales Growth in China in Improved Half Year Results
TruScreen – Commercial Breakthrough in Saudi Arabia
Shareholder Meeting Results
Annual Meeting Presentation
TruScreen Stakeholder Newsletter August 2023
Strong Sales growth in Q1 FY2024 (April to June 2023)
TruScreen Opto-electrical Technology Recognised
Truscreen Annual meeting Notice
Director and Officer Change of Interest Notice
TruScreen Preliminary Final Results March 2023
TruScreen Preliminary Results March 2023 Announcement
TruScreen Preliminary Final Results Summary
CSCCP Cervical Cancer Screening Guideline to Include TruScreen Technology
TruScreen Recognised in Authoritative China Blue Paper
Director and Officer Change of Interest Notice
Growing Recognition for TruScreen
Director and Officer Disclosure Notices
TruScreen Rights Offer closes
Outstanding Clinical Evaluation Results from Saudi Arabia
TruScreen Rights Issue Offer Closing Soon
Publication of Research Report
China Ramps Up for Public Health Check Centres
TruScreen Raises $600,000 in Initial Share Placement
TruScreen Rights Issue Offer Opens
Pro Rata Renounceable Rights Issue Offer Document
TruScreen to Lodge a Pro Rata Renounceable Rights Issue
TruScreen Corporate Action Notice
Director and Officer Disclosure Notice – Mr Christopher Horn
Director and Officer Disclosure Notice – Mr Anthony Ho
TruScreen Half Year Results Template
NZX | ASX - HALFYR | Half Yearly Report, Half Year Accounts
TruScreen Half Year Results
NZX | ASX - HALFYR | Half Yearly Report, Half Year Accounts
TruScreen Stakeholder Newsletter November 2022
Hosts Global Medical Symposium, Expands Reach in Vietnam
Director and Officer Disclosure Notice
Director and Officer Disclosure Notice
Dr Beata Edling Appointed CEO of TruScreen Group
Shareholder Meeting Results
Annual Meeting Presentation
TRU Signs Five Year Manufacturing Agreement for SUS Supply
Director and Officer Disclosure Notice
Relaunch of TruScreen Devices in Xinjiang Uygur Region
TruScreen-based cervical cancer screening centre opens in Mexico City
TruScreen Shareholder Meeting
TruScreen Director Nominations Closing Date
SPH Notice – Waitara Trustees Limited
Director & Officer Disclosure Notice
Director & Officer Disclosure Notice
Director & Officer Disclosure Notice
Director & Officer Disclosure Notice
TruScreen FY22 Preliminary Results
Provision for Impairment of Non Current Assets
COGA Trial validates superiority of TruScreen cervical cancer screening method
TruScreen achieves significant milestones with Distributors
Disclosure of Directors and Senior Managers Relevant Interests
Issue of Unlisted Options
TruScreen Makes Progress in Key Markets Worldwide
NZX | ASX - General, Progress Report
Half Year Report September 2021
NZX | ASX - HALFYR | Half Yearly Report, Half Year Accounts
TruScreen Results Announcement Template September 2021
NZX | ASX - HALFYR | Half Yearly Report, Half Year Accounts
TruScreen September 2021 Results Announcement
NZX | ASX - HALFYR | Half Yearly Report, Half Year Accounts
TruScreen Device – Milestones Achieved on Growth Strategy
Clinical Trial Results Highlight Efficacy of TRU Technology
Director and Officer Disclosure Notice
Ceasing to be Substantial Shareholder Browns Island Holdings Limited
Stakeholder Newsletter – May 2021
NZX | ASX - General | Periodic Reports - Other, Progress Report, Letter to Shareholders
Preliminary Final Report March 2021
NZX | ASX - FLLYR | Preliminary Final Report
Appendix 4E & Preliminary Final Results March 2021
ASX - Preliminary Final Report
Preliminary Results Announcement
NZX | ASX - FLLYR | Preliminary Final Report
Final Director’s Interest Notice
Director and Officer Disclosure Notice
TruScreen Board Appointment
TruScreen Executive Leadership Change
SPH Notice – Masfen Securities Limited and Others
Substantial Shareholder Notice – Browns Island Holdings Limited
Substantial Shareholder Notice – Consolidated Nominees Pty Ltd
Change of Director’s Interest Notice
ASX - Change of Director's Interest Notice
Annual Report for the year ended 31 March 2020
ASX - Period Reports | ASX Admission to Official List
Top 20 Shareholders List
ASX - Top 20 Shareholders | Admission to Official List
Distribution Schedule
ASX - Issued Capital | Admission to Official list
Reviewed pro-forma statement of financial position
ASX - Period Reports | Admission to Official list
Accounts for the six months ended 30 September 2020
ASX - Periodic Reports | Admission to Official List
Annual Report for the year ended 31 March 2019
ASX - Period Reports | Admission to Official List
Constitution
ASX - Admission to Official List | Constitution
Information Form and Checklist Annexure 2
ASX - Admission to Official List | Company Administration - Other
Information Form and Checklist
ASX - Admission to Official List | Company Administration - Other
Appendix 1C
ASX - Issued Capital - Other | Admission to Official list
ASX Market Announcement – Admission and Quotation
ASX - Admission to Official List | Commencement of Official Quotation
Offer Closes Significantly Oversubscribed
ASX Approves TruScreen to Official List – Offer to Close 18 December 2020
Public Offer Acceptance Reaches Target NZ$1.5 Million
Opening of Public Offer and Publication of Research Report
Application for Dual Listing of TruScreen’s Shares on the ASX
TruScreen Unaudited Interim Condensed Financial Statements 30 September 2020
TruScreen Results Template 30 September 2020
TruScreen Results Half Year Ended 30 September 2020
Recording of TruScreen Group Limited ASM Virtual Meeting
Annual Meeting of Shareholders Results
Juliet Hull Elected Non-Executive Director
Truscreen Strengthens Market Presence in Central Europe
Truscreen Director Nominations Closing Date
Truscreen Stakeholders Newsletter July 2020
Truscreen NZX Results Announcement Form March 2020
Truscreen Financial Results for the year ended 31 March 2020
Truscreen Capital Change Notice
NZX | Truscreen-Capital-Change-Notice
Truscreen Priority Allocation of $1 Million Closed
Results Announcement Date – Reliance on NZX Class Waiver
Truscreen Capital Change Notice
Director Disclosure Notices
Truscreen Closes Public Pool Offer Fully Subscribed
Truscreen Limited Capital Change Notice
TruScreen Key Investment Highlights
Notice of Offer of Same Class Financial Products for Issue
Truscreen expands in China
Truscreen Limited Corporate Action Notice
Truscreen Investor Presentation
TruScreen expands to Vietnam with Ministry of Health Approval
TruScreen Appoints Ex-Johnson & Johnson UK Executive as CEO
TruScreen Manufacturing and Supply Chain Update
Outstanding Results from Truscreen Indian Screening Trial
TruScreen Unaudited Preliminary Results for the Half Year Ending 30 September 2019
TruScreen Interim Results to 30 September 2019
WHO cervical cancer elimination strategy opens up TruScreen’s market opportunity
Interim Unaudited Financial Statements
Resignation of Chief Executive Officer
Director and Officer Disclosure Notices
Screening results in Hunan, China exceed expectations
Director Ongoing Disclosure Notice
TruScreen Director’s Certificate
TruScreen Director Nominations Closing Date
TruScreen Completes Capital Raising
TruScreen Limited 2019 Annual Report
Cervical Cancer Technology Landscape – Unitaid & WHO Publication
Preliminary Financial Statements
TruScreen FY19 results show sales up, costs down, reduced loss
TruScreen Preliminary Results FY19 Appendix
World Health Organisation Recognises TruScreen Cervical Cancer Screening Device
Market Update – March 2019
TruScreen Significant Sales Increase, Reduced Loss in Half Year
TruScreen Preliminary Results
TruScreen Interim Results to 30 Sept 2018
Waivers and Rulings for Migration to NZX Main Board
L&Q Notice: TruScreen Limited Ordinary Shares (“TRU”)
TruScreen December Newsletter
TRU Migration from NZAX Market to NZX Main Board
TRU Appoints CFO and Company Secretary
TRU Appointment of Alternate Director
TruScreen Reports 523% Sales Growth for First Half Year
TruScreen Announces New Chairman
Shareholder Presentation Annual Meeting 2018
TruScreen’s Annual Meeting – Chairman’s Presentation
Results of Annual Shareholder Meeting
TruScreen Share Purchase Plan Details
TruScreen HIV African Initiative Update
TruScreen Announces Share Purchase Plan Details
TruScreen Share Placement September 2018
TRU Capital Raising August 2018
TruScreen Announces HIV African Initiative
Truscreen Limited – 2018 Annual Report
2018 Annual Review Letter
TruScreen Limited: Annual Report and Section 209C Notice
TruScreen Commences Large Scale Chinese Pilot with CDC
TruScreen’s New Production Facility Fully Operational & Delivers Significant Improvement In Device Profitability
TruScreen Makes Strong Progress in First Quarter FY19
Preliminary Consolidated Financial Statements NZX Appendix
Preliminary Consolidated Financial Statements
TruScreen Unaudited Preliminary Results for the Year Ended 31 March 2018
TruScreen June Newsletter
Cancer Marketing Expert Joins TruScreen Board
TruScreen Appoints New Director
TruScreen Half Year Report and Interim Financial Statements
TruScreen January Newsletter
TruScreen Receives CFDA Approval for its Second Generation Device in China
TruScreen Passes CFDA Technical Assessment for its Second Generation Device in China
World-renowned medical specialist joins TruScreen Board 19 October 2017
Annual Meeting of Shareholders
TruScreen Director Nominations Closing Date
TruScreen Annual Report 2017
TruScreen Preliminary Results for the Year Ended 31 March 2017
TruScreen Limited Preliminary Consolidated Financial Statements
TruScreen Limited NZX Appendix 1 Release
TruScreen April 2017 Newsletter
TruScreen Investor Briefing Presentation March 2017
TruScreen Interim Results to 30 September 2016